模块化和自动化合成小分子合物和小分子合物,用于 cathepsin B 介导的无痕释放有效载荷
Cheng Jin1,2, Siqi Li1,3, Katherine A Vallis3
1Department of Chemistry, Chemistry Research Laboratory, University of Oxford 12 Mansfield Road Oxford OX1 3TA UK tom.brown@chem.ox.ac.uk.
RSC chemical biology
|August 2, 2024
概括
研究人员开发了一种新型可切割的链接器,Val-Ala (NB),用于寡核酸-药物合物. 这种连接器可以在细胞内无痕释放治疗有效载荷,增强寡核酸治疗效果.
科学领域:
- 药用化学 医学化学
- 氧核酸治疗药物 治疗药物
- 生物结合的生物结合
背景情况:
- 开发有效的寡核酸疗法需要有效的方法来附着小分子.
- 可切割连接器对于释放*in vivo*的治疗有效载荷至关重要,但合适的选择有限.
- 无痕释放有效载荷对于最大限度地提高治疗效果和最大限度地减少目标外影响至关重要.
研究的目的:
- 引入一种新的cathepsin B-可切割二酸胺酸,Val-Ala (NB),用于合成寡核酸-小分子合物.
- 为了证明Val-Ala的实用性,作为一种模块化和刺激响应的药物输送链接器.
- 为了满足对连接器的需求,使无痕有效载荷释放 *in vivo*.
主要方法:
- 通过使用Val-Ala (NB) 光胺,自动合成寡核酸小分子合物.
- 保护二链接器与光可变的2-基基组,以提高DNA合成期间的稳定性.
- 乙二被乙二细胞内裂变,然后通过内源性酸酶释放有效载荷.
主要成果:
- 成功合成了包含Val-Ala (NB) 链接器的寡核酸小分子合物.
- 效率高的细胞内裂变的Val-Ala (NB) 链接器由甲素B.
- 释放一个有效载荷-酸盐,随后由细胞酶转化为自由有效载荷.
结论:
- 瓦尔-阿拉 (Val-Ala) 链接器提供了一个模块化方法,用于创建寡核酸-药物合物.
- 这种链接器促进了由细胞内甲素B介导的刺激反应性药物释放.
- 瓦尔-阿拉 (Val-Ala) 是一个有前途的可切割的链接器,用于推进基于寡核酸的治疗方法.
相关概念视频
Modified-Release Drug Delivery Systems: Stimuli-Activated
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also called...
Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...


